BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 16973003)

  • 21. Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.
    Nucci M; Anaissie E
    Clin Infect Dis; 2009 Oct; 49(8):1211-25. PubMed ID: 19769539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation and monitoring of response to therapy in multiple myeloma.
    Rajkumar SV; Dispenzieri A
    Haematologica; 2005 Oct; 90(10):1305-8. PubMed ID: 16219565
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of multiple myeloma in the targeted therapy era.
    Saad AA; Sharma M; Higa GM
    Ann Pharmacother; 2009 Feb; 43(2):329-38. PubMed ID: 19193585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloma--new approaches to combined nephrological-haematological management.
    Haubitz M; Peest D
    Nephrol Dial Transplant; 2006 Mar; 21(3):582-90. PubMed ID: 16396976
    [No Abstract]   [Full Text] [Related]  

  • 25. Transplantation for amyloidosis.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar S
    Curr Opin Oncol; 2007 Mar; 19(2):136-41. PubMed ID: 17272986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of thalidomide in previously untreated patients with multiple myeloma.
    Musto P; D'Auria F; Pietrantuono G; Bringhen S; Morabito F; Di Raimondo F; Pozzi S; Sacchi S; Boccadoro M; Palumbo A; ;
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1569-80. PubMed ID: 18925849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Two cases of multiple myeloma with the successful endoprosthesis of the femoral head showed a satisfactory response to AAAP-therapy for relapse with extramedullary myeloma (author's transl)].
    Maruo K; Yoshikawa H; Kuboyama K; Yokoe K; Shido T
    Rinsho Ketsueki; 1980 Feb; 21(2):220-32. PubMed ID: 7411867
    [No Abstract]   [Full Text] [Related]  

  • 28. Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.
    Cavo M; Di Raimondo F; Zamagni E; Patriarca F; Tacchetti P; Casulli AF; Volpe S; Perrone G; Ledda A; Ceccolini M; Califano C; Bigazzi C; Offidani M; Stefani P; Ballerini F; Fiacchini M; de Vivo A; Brioli A; Tosi P; Baccarani M
    J Clin Oncol; 2009 Oct; 27(30):5001-7. PubMed ID: 19720903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple myeloma].
    Kawanishi K; Kanamaru A
    Ryoikibetsu Shokogun Shirizu; 2000; (32):413-7. PubMed ID: 11212761
    [No Abstract]   [Full Text] [Related]  

  • 30. Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation.
    Sharma A; Lokeshwar N; Raina V; Mohanti BK; Kumar R
    Natl Med J India; 2007; 20(3):121-4. PubMed ID: 17867615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutic effect of interferon and adrenal hormone for children with Guillain-Barre syndrome].
    Yang XM; Zheng P; Haier NS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Mar; 15(3):153. PubMed ID: 12831618
    [No Abstract]   [Full Text] [Related]  

  • 32. [Guidelines for the diagnosis and management of multiple myeloma by the Japan Myeloma Study Group].
    Shimizu K;
    Rinsho Ketsueki; 2005 Jun; 46(6):424-32. PubMed ID: 16447724
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapeutic progress--review XII. Treatment of multiple myeloma.
    Oakley JE; Franklin IM
    J Clin Hosp Pharm; 1984 Mar; 9(1):15-20. PubMed ID: 6371060
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multiple myeloma--pathophysiology and treatment].
    Gahrton G; Björkholm M; Mellstedt H; Ost A
    Lakartidningen; 1988 May; 85(19):1707-10, 1713. PubMed ID: 2453765
    [No Abstract]   [Full Text] [Related]  

  • 35. Multiple myeloma in a 50-year-old with an HLA-identical sibling.
    Koreth J
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1247-8. PubMed ID: 17889363
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple myeloma. Progress is being made.
    Mayo Clin Health Lett; 2011 Mar; 29(3):4-5. PubMed ID: 21553706
    [No Abstract]   [Full Text] [Related]  

  • 37. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric relapse of plasma-cell myeloma after stem-cell transplantation.
    Pollheimer VS; Pollheimer MJ; Eherer AJ; Langner C
    Gastrointest Endosc; 2007 Jul; 66(1):179-80; discussion 180. PubMed ID: 17451699
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan.
    Vela-Ojeda J; García-Ruiz-Esparza MA; Padilla-González Y; Gómez-Almaguer D; Gutiérrez-Aguirre CH; Gómez-Rangel D; Morales-Toquero A; Ruiz-Delgado GJ; Delgado-Lamas JL; Ruiz-Argüelles GJ
    Ann Hematol; 2007 Apr; 86(4):277-82. PubMed ID: 17262193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Initial therapy in multiple myeloma: investigating the new treatment paradigm.
    Kettle JK; Finkbiner KL; Klenke SE; Baker RD; Henry DW; Williams CB
    J Oncol Pharm Pract; 2009 Sep; 15(3):131-41. PubMed ID: 19276138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.